A number of studies have demonstrated sustained weight loss post-medication removal
A few terms you may encounter during screening: GLP-1 injection / GLP-1 shot
In summary, GLP-1GIPLani outperforms GLP-1RGIPR co-agonism and semaglutide to yield greater body weight loss and further improvement of glucose metabolism, with the latter being mediated by improved insulin sensitivity and enhanced suppression of endogenous glucose production
A common side effect of taking GLP-1 medications is nausea
GLP-1R mRNA expression analyses was performed by RT- and qPCR as previously described [27]
However, no significant differences were detected in other outcomes, including nonmotor symptoms, cognition, finger tapping, walking speed, and levodopa equivalent dose [97]